<?xml version="1.0" encoding="UTF-8"?>
<p>Further informative data are shown for the typical symptoms domain (
 <xref ref-type="supplementary-material" rid="S5">Supplementary Table 4</xref>), the QoL domain (
 <xref ref-type="supplementary-material" rid="S6">Supplementary Table 5</xref>), and the dynamics of the ACSS and for the assessment of overall efficacy by investigator and patient (
 <xref ref-type="supplementary-material" rid="S7">Supplementary Table 6</xref>) by visit and treatment in the full analysis set.
</p>
